Belgumba Pranesh

Belgumba Pranesh

Director Director DIN 06800853
DIN 06800853 First appointment Dec 2013 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2013
Shareholding value Locked Premium profile

About Belgumba Pranesh

Data last updated:

Belgumba Pranesh has 12 years in corporate governance. Formerly with 1 company, such as Bal Pharma Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06800853
Primary Designation Director
First Appointment 31 Dec 2013
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Bal Pharma Limited L85110KA1987PLC008368
Nominee Director31 Dec 20131987Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bal Pharma Limited
Premium access

Shareholding and investment profile for Belgumba Pranesh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Belgumba Pranesh

Belgumba Pranesh has 12 years in corporate governance. Formerly with 1 company, such as Bal Pharma Limited. Engaged in General Business. Contributes to corporate operations.

Belgumba Pranesh is associated with 0 companies as a director.

Belgumba Pranesh has expertise in General Business.

Belgumba Pranesh has 12 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available